Publications by authors named "Jason Gotlib"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,220

Total Likes

473

Extended Reach

2,292,496

Social Features

129
R
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.
Marina Kremyanskaya, Andrew T Kuykendall, Naveen Pemmaraju, Ellen K Ritchie, Jason Gotlib, Aaron Gerds, Jeanne Palmer, Kristen Pettit, Uttam K Nath, Abdulraheem Yacoub

N Engl J Med· February 2024

Videos about Article: user user user 1

4 2 125 6 34

View All Article and Social Media Activity
A
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, Alexander Baek, Mounzer Agha, Jason Gotlib

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib.
Emily C Liang, Cecelia Perkins, Rong Lu, Hongliang Shi, Saša Dimitrijević, Jason Gotlib

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study.
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H Radia, Johannes Lübke

Leuk Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium.
Hirsh D Komarow, Gunnar Nilsson, Yoshimichi Okayama, Yoseph Mekori, Ana Olivera, Jason R Gotlib

J Allergy Clin Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib for Myeloid/Lymphoid Neoplasms with Rearrangement.
Srdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Jay L Patel, Alessandro Rambaldi, Jason Gotlib

NEJM Evid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj, Jason Gotlib

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to a How I Treat series on myeloproliferative neoplasms.
Jason Gotlib

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.
Federico Mosna, Erika Borlenghi, Mark Litzow, John C Byrd, Cristina Papayannidis, Jason R Gotlib

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.
Axel Rüfer, Henning Nilius, Olivier Hermine, Marek Niedoszytko, Joanne N G Oude Elberink, Jason Gotlib

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.
Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose, Jason Gotlib

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan-Carlos Hernandez-Boluda, Prithviraj Bose, Jason Gotlib

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Jason Gotlib

Allergy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis.
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Alessandro M Vannucchi, Jason Gotlib

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Johannes Lübke, Alicia Schmid, Deborah Christen, Hanneke N G Oude Elberink, Lambert F R Span, Jason Gotlib

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, Haris Ali, Mariana Castells

J Natl Compr Canc Netw· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
William Shomali, Jason Gotlib

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee.
Donal P McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari, Jason Gotlib

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to a review series on RNA therapeutics in hematology.
Jason Gotlib

Blood· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, Karin Hartmann, Wolfgang R Sperr, Jason Gotlib

J Allergy Clin Immunol Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.
Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Jason Gotlib

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches.
Pramod C Nair, Jacob Piehler, Denis Tvorogov, David M Ross, Angel F Lopez, Jason Gotlib

Blood Cancer Discov· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Sa A Wang, Attilio Orazi, Jason Gotlib, Andreas Reiter, Alexandar Tzankov

Am J Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of blast phase in myelofibrosis according to anemia severity.
Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Jason Gotlib

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann

NEJM Evid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis